L&G Europe ex UK Equity UCITS ETF | LGEURegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 7.1 | 17.6 | -7.5 | 15.7 | 5.0 | |
+/-Cat | -2.3 | 2.2 | 1.2 | 2.2 | 0.4 | |
+/-B’mrk | -0.8 | 0.4 | -0.1 | 0.7 | 0.3 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
Closing Price 06/05/2024 | EUR 16.55 | |
Day Change | 0.79% | |
Morningstar Category™ | Europe ex-UK Equity | |
Volume | 329 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BFXR5V83 | |
Fund Size (Mil) 03/05/2024 | EUR 263.32 | |
Share Class Size (Mil) 03/05/2024 | EUR 263.32 | |
Ongoing Charge 14/02/2024 | 0.10% |
Investment Objective: L&G Europe ex UK Equity UCITS ETF | LGEU |
The investment objective of the L&G Europe ex UK Equity UCITS ETF (the “Fund”) is to provide exposure to the large and mid-cap equity market in the developed market countries in Europe, excluding the United Kingdom. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 07/11/2018 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Solactive Core DM Europe exUK L&M NR EUR | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for L&G Europe ex UK Equity UCITS ETF | LGEU | 03/05/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 4.85 |
ASML Holding NV | Technology | 4.42 |
Nestle SA | Consumer Defensive | 3.36 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 2.71 |
SAP SE | Technology | 2.34 |
Increase Decrease New since last portfolio | ||
L&G Europe ex UK Equity UCITS ETF | LGEU |